Results 1 to 10 of about 195,947 (275)
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Journal of Tropical Medicine, 2021 Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America.
Pashupati Pokharel +2 more
doaj +2 more sources
Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens.
Infectious Disease Clinics of North America, 2019 Visceral leishmaniasis (VL) is a vector-borne parasitic disease targeting tissue macrophages. It is among the most neglected infectious diseases. Classical manifestations of VL include chronic fever, hepatosplenomegaly, and pancytopenia. Most cases can be detected through serologic and molecular testing.
J. van Griensven, E. Diro
semanticscholar +4 more sources
BMC Infectious Diseases, 2019 Background Malaria and leishmaniasis are the two largest parasitic killers in the world. Due togeographical overlap of these diseases, malaria-visceral leishmaniasis co-infections occur in large populations and exist in different areas even if they have ...
Yibeltal Aschale +5 more
doaj +2 more sources
Human visceral leishmaniasis and relationship with vector and canine control measures
Revista de Saúde Pública, 2018 OBJECTIVE Estimate the coverage of control measures of visceral leishmaniasis and relate them with the occurrence of human visceral leishmaniasis in endemic urban area.
Danielle Nunes Carneiro Castro Costa +9 more
doaj +2 more sources
Changing Pattern of Visceral Leishmaniasis, United Kingdom, 1985-2004 [PDF]
Emerging Infectious Diseases, 2006 A 20-year (1985–2004) retrospective review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean countries and HIV infection were associated with visceral leishmaniasis. Diagnosis was often delayed.
Aeesha N.J. Malik +3 more
doaj +2 more sources
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
Clinical Microbiology Reviews, 2018 Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination. Systematic research by geographical regions has shown that a universal treatment is far from today's ...
Fabiana Alves +2 more
exaly +2 more sources
Brazilian Journal of Biology, 2018 Zoonotic visceral leishmaniasis (ZVL), caused by protozoans of the genus Leishmania, it is a worldwide of great importance disease. In the northeast region of Brazil, the state of Alagoas has an endemic status for ZVL.
M. A. N. Rocha +3 more
doaj +2 more sources
Vulnerability to the transmission of human visceral leishmaniasis in a Brazilian urban area
Revista de Saúde Pública, 2017 OBJECTIVE To analyze the determinants for the occurrence of human visceral leishmaniasis linked to the conditions of vulnerability. METHODS This is an ecological study, whose spatial analysis unit was the Territorial Analysis Unit in Araguaína, State ...
Celina Roma Sánchez de Toledo +5 more
doaj +2 more sources
Role of Cytokines in Experimental and Human Visceral Leishmaniasis
Frontiers in Cellular and Infection Microbiology, 2021 Visceral Leishmaniasis (VL) is the most fatal form of disease leishmaniasis. To date, there are no effective prophylactic measures and therapeutics available against VL.
M. Samant +3 more
semanticscholar +1 more source
Therapeutic Advances in Infectious Disease, 2021 Visceral leishmaniasis carries a significant burden of disease in the Americas with up to 7000 cases reported annually. There are several reports of autochthonous visceral leishmaniasis cases in the Caribbean, including the Dominican Republic, Guadalupe,
Gerardine García Oronoz +4 more
doaj +1 more source